[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Udg Healthcare Public Limited Company LSE:UDG London Ordinary Share IE0033024807 ORD EUR0.05 (CDI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 1,078.00 1,077.00 1,078.00 1,079.00 1,077.00 1,079.00 2,020,075 16:25:25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food & Drug Retailers 1,161.1 98.2 33.6 34.2 2,710

Form 8.3 - The Vanguard Group, Inc.: UDG Healthcare plc

18/06/2021 2:59pm

UK Regulatory (RNS & others)


The Vanguard Group, Inc. ( IRSH) 
Form 8.3 - The Vanguard Group, Inc.: UDG Healthcare plc 
18-Jun-2021 / 14:59 GMT/BST 
Dissemination of a Regulatory Announcement, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Ap19 
 
FORM 8.3 
 
IRISH TAKEOVER PANEL 
 
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 
 
DEALINGS BY PERSONS WITH IN INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 
 
1.  KEY INFORMATION 
 
Name of person dealing (Note 1)                                                  The Vanguard Group, Inc. 
Company dealt in                                                                 UDG Healthcare plc 
Class of relevant security to which the dealings being disclosed relate (Note 2) EUR0.05 Ordinary Shares 
Date of dealing                                                                  16 June 2021 

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

                                            Long             Short 
                                            Numbers    (%)   Numbers (%) 
(1) Relevant securities                     11,704,996 4.65% 
(2) Derivatives (other than options) 
(3) Options and agreements to purchase/sell 
Total                                       11,704,996 4.65% 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:                  Long        Short 
                                             Numbers (%) Numbers (%) 
(1) Relevant securities 
(2) Derivatives (other than options) 
(3) Options and agreements to purchase/sell 
Total 

Ap20

1. Dealings (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities  Price per unit (Note 5) 
Purchase      3,600                          10.47 GBP 
Sale          13,016                         10.50 GBP 
Sale          50,968                         10.48 GBP 

(b) Derivatives transactions (other than options transactions)

Product name,  Nature of transaction Number of relevant securities Price per unit 
e.g. CFD       (Note 6)              (Note 7)                      (Note 5) 
Not Applicable 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, Writing, selling,    Number of securities to               Type, e.g.               Option money paid/ 
              purchasing, varying  which the option relates     Exercise American,         Expiry received per unit 
e.g. call     etc.                 (Note 7)                     price    European etc.     date   (Note 5) 
option 
Not 
Applicable 

(ii) Exercising

Product name,                         Exercise price per unit (Note 5) 
                 Number of securities 
e.g. call option 
Not Applicable 

(e) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction         Price per unit 
                      Details 
(Note 8)                      (if applicable) (Note 5) 
Not Applicable 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating 
to the voting rights of any relevant securities under any option referred to on this form or relating to the voting 
rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is 
referenced. If none, this should be stated. 
 
 
 
 

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure                                               18 June 2021 
Contact name                                                     Shawn Acker 
Telephone number                                                 001-610-669-8989 
If a connected EFM, name of offeree/offeror with which connected 
If a connected EFM, state nature of connection (Note 10) ----------------------------------------------------------------------------------------------------------------------- 
Category Code: RET - UDG Healthcare plc 
TIDM:          IRSH 
LEI Code:      5493002789CX3L0CJP65 
Sequence No.:  112337 
EQS News ID:   1209822 
 
End of Announcement  EQS News Service 
=------------------------------------------------------------------------------------
 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1209822&application_name=news 
 

(END) Dow Jones Newswires

June 18, 2021 09:59 ET (13:59 GMT)

1 Year Udg Healthcare Public Chart

1 Year Udg Healthcare Public Chart

1 Month Udg Healthcare Public Chart

1 Month Udg Healthcare Public Chart
ADVFN Advertorial
Your Recent History
LSE
UDG
Udg Health..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210805 03:32:20